Benzinga | Aug 2, 2021 04:24PM EDT

Verastem Oncology Q2 EPS $(0.08) Up From $(0.12) YoY, Sales $500.00K Down From $4.31M YoY

Verastem Oncology (NASDAQ:VSTM) reported quarterly losses of $(0.08) per share. This is a 33.33 percent increase over losses of $(0.12) per share from the same period last year. The company reported $500.00 thousand in sales this quarter. This is a 88.39 percent decrease over sales of $4.31 million the same period last year.